VEGFR2/CD309 anticorps (pTyr996)
Aperçu rapide pour VEGFR2/CD309 anticorps (pTyr996) (ABIN2624476)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr996
-
Specificité
- This KDR/FLK1 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y996 of human KDR/FLK1.
-
Purification
- Affinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: ELISA (1:1000), IHC (1:50 - 1:100), WB (1:100 - 1:500)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- KDR / VEGFR2
-
Sujet
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
ID gène
- 3791
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-